Literature DB >> 30963222

Vestibular migraine treatment and prevention.

A Lapira1,2,3.   

Abstract

Vestibular migraine probably represents the second most common cause of vertigo after benign positional vertigo, by far exceeding Ménière disease. There are still relatively few published reports on vestibular migraine management, despite its enormous importance in daily practice. In 2003 the first clinical definition of vestibular migraine was proposed. Studies published before 2003 used variable terms for vestibular migraine. Some authors recommend treating vestibular migraine using multiple drugs; others have focused on using only one drug. Although at present it is not possible to quantify the effects of the treatments proposed, some recommendations can be made.

Entities:  

Keywords:  Episodic vertigo; Migraine disorders; Pharmacotherapy; Vertigo; Vestibular apparatus

Mesh:

Year:  2019        PMID: 30963222     DOI: 10.1007/s00106-019-0661-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

1.  Risk factors of vestibular migraine-related brain white matter lesions.

Authors:  Yu Shen; Defu Li; Qian Cao; Mengyao Hu; Zhou Hou; Lijun Xu; Yanping Li; Daojun Hong
Journal:  Acta Neurol Belg       Date:  2022-09-07       Impact factor: 2.471

Review 2.  Vestibular migraine: the chameleon in vestibular disease.

Authors:  Minping Li; Xue Xu; Weiwei Qi; Yingyin Liang; Yongxin Huang; Haiwei Huang
Journal:  Neurol Sci       Date:  2021-03-05       Impact factor: 3.830

3.  New Anti-CGRP Medications in the Treatment of Vestibular Migraine.

Authors:  Justin L Hoskin; Terry D Fife
Journal:  Front Neurol       Date:  2022-01-27       Impact factor: 4.003

Review 4.  The Treatment of Vestibular Migraine: A Narrative Review.

Authors:  Youjin Shen; Xiaokun Qi; Tingyu Wan
Journal:  Ann Indian Acad Neurol       Date:  2020-02-11       Impact factor: 1.383

Review 5.  Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit.

Authors:  Monica P Mallampalli; Habib G Rizk; Amir Kheradmand; Shin C Beh; Mehdi Abouzari; Alaina M Bassett; James Buskirk; Claire E J Ceriani; Matthew G Crowson; Hamid Djalilian; Joel A Goebel; Jeffery J Kuhn; Anne E Luebke; Marco Mandalà; Magdalena Nowaczewska; Nicole Spare; Roberto Teggi; Maurizio Versino; Hsiangkuo Yuan; Ashley Zaleski-King; Michael Teixido; Frederick Godley
Journal:  Front Neurol       Date:  2022-01-03       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.